Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PhagoPied: Phage Therapy vs Placebo for Diabetic Foot Ulcers
NCT02664740Phase 2Not yet recruiting
- Sponsor
- CHU Nîmes
- Start
- Sep 2026
- Primary completion
- Nov 2028
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic foot ulcer (DFU) and staphylococcal infection (2 arms), sponsored by CHU Nîmes. Primary endpoint: Relative reduction in wound surface area at 12 weeks. Planned start Sep 2026; status: not yet recruiting.
02
Conditions
diabetic foot ulcer (DFU)staphylococcal infection
Beyond the preview
Go deeper on NCT02664740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02664740.